MXEQX
Price
$31.84
Change
-$0.03 (-0.09%)
Updated
Jun 5 closing price
Net Assets
1.62B
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

MXEQX vs RMEBX

Header iconMXEQX vs RMEBX Comparison
Open Charts MXEQX vs RMEBXBanner chart's image
Empower Large Cap Value I
Price$31.84
Change-$0.03 (-0.09%)
VolumeN/A
Net Assets1.62B
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
MXEQX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MXEQX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXEQX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. MXEQX (1.62B). RMEBX pays higher dividends than MXEQX: RMEBX (1.16) vs MXEQX (0.06). MXEQX was incepted earlier than RMEBX: MXEQX (31 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than MXEQX (1.00). MXEQX (31.00) and RMEBX (31.00) have comparable annual turnover. MXEQX has a lower initial minimum investment than RMEBX: MXEQX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. MXEQX (3.01). MXEQX return over 5 years is better than : 62.09 vs. RMEBX (49.85).
MXEQXRMEBXMXEQX / RMEBX
Total Expense Ratio0.961.0790%
Annual Report Gross Expense Ratio1.001.0793%
Fund Existence31 years11 years-
Gain YTD3.3405.34962%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.62B105B2%
Annual Yield % from dividends0.061.166%
Returns for 1 year3.018.3036%
Returns for 3 years20.1217.96112%
Returns for 5 years62.0949.85125%
Returns for 10 years73.6168.21108%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA